Literature DB >> 4053054

Induction of granulocytic hyperplasia, thymic atrophy, and hypercalcemia by a selected subpopulation of a murine mammary adenocarcinoma.

E Thomas, D C Smith, M Y Lee, C Rosse.   

Abstract

Three tumor cell subpopulation lines derived from a single, spontaneously occurring BALB/cfC3H mammary tumor were evaluated for their ability to cause a leukemoid effect in mice. One of the BALB/cfC3H tumor cell lines (410.4) produced leukocytosis with neutrophilia, hypercalcemia, and thymic atrophy. A second line (66) produced none of these effects. The third line (168) was intermediate in its ability to affect neutrophil counts and splenomegaly but did not produce thymic atrophy or hypercalcemia. These studies demonstrated that the hemopoietic effect of tumor cells derived from a single tumor was variable and that a tumor cell line which caused neutrophilia also induced hypercalcemia and thymic atrophy, the same association that was reported previously in the case of murine CE mammary carcinoma. These observations will be useful in the further investigation of pathophysiology of tumor-induced leukemoid reactions, hypercalcemia, and other paraneoplastic syndromes.

Entities:  

Mesh:

Year:  1985        PMID: 4053054

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Influence of breast cancer on thymic function in mice.

Authors:  Diana M Lopez; Vijaya Charyulu; Becky Adkins
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Isolation of a murine osteoclast colony-stimulating factor.

Authors:  M Y Lee; D R Eyre; W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 3.  Insights into thymic involution in tumor-bearing mice.

Authors:  Roberto Carrio; Diana M Lopez
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.

Authors:  Sujun Sun; Haiyu Ji; Yingying Feng; Yu Kang; Juan Yu; Anjun Liu
Journal:  Cancer Manag Res       Date:  2018-03-05       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.